What outcomes should we target to improve health outcomes and overall well-being?

The Rippel Foundation has an interesting framework to describe the dimensions for improving health and overall individual quality of life. This is part of their mission to guide “transformational change that supports better health and well-being for all—a future where everyone thrives, without exception.” The organization identified relevant desirable outcomes of health and wellness as…

Why doctors don’t like insurance

If you go to the doctor or dentist in the US, you often can get a discount if you pay out of pocket as compared to paying through insurance. Why is that the case? Wouldn’t the physician like to get a big insurance company to pay them as compared to potentially incurring credit card fees…

Requiem for odds ratios?

Health Services Research has decided that studies using logistic regressions should report marginal effects rather than odds ratios. Why did they make this decision? A paper by Norton et al. (2024) identifies 3 key factors. Intelligibility. Consider the case of examining the impact of whether a hospital is in a disadvantaged area on readmission rates.…

FTC report on PBMs

Last week, the Federal Trade Commission (FTC) released a report titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” While I won’t get into an analysis of the specific arguments FTC made, the report does have a number of interesting statistics and graphics on pharmacy benefit managers (PBMs). Some…

How adoption of new pharmaceuticals can impact US health system reimbursement under alternative payment models

This is the title of a new paper I have out today at JMCP with co-authors Shanshan Wang, Jaehong Kim, Slaven Sikirica, and Alexander Sandhu with the subtitle “An economic model measuring the impact of sotagliflozin among patients with heart failure and diabetes“. The abstract is below: BACKGROUND: Heart failure (HF) is among the leading…